Inventor

GELFAND ERWIN

US7 patents

⚠️ This page may combine multiple inventors who share the name “GELFAND ERWIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NAT JEWISH HEALTH

2 patents

US7582300B2Sep 1, 2009

Modulation of gamma delta T cells to regulate airway hyperresponsiveness

NAT JEWISH HEALTH8 citations80

US9383374B2Jul 5, 2016

Methods to determine susceptibility to treatment with leukotriene modifiers

NAT JEWISH HEALTH0 citations44

LAHN MICHAEL F

1 patent

US8178098B2May 15, 2012

Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies

LAHN MICHAEL F49 citations87

NAT JEWISH MED & RES CENTER

1 patent

US6737398B1May 18, 2004

Modulation of γδ T cells to regulate airway hyperresponsiveness

NAT JEWISH MED & RES CENTER5 citations69

AVENTIS BEHRING GMBH

1 patent

US6537519B2Mar 25, 2003

Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases

AVENTIS BEHRING GMBH11 citations69

TOLEROGEN LTD

1 patent

US7306782B2Dec 11, 2007

Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases

TOLEROGEN LTD2 citations52

RABINOVITCH NATHAN

1 patent

US8685740B2Apr 1, 2014

Methods to determine susceptibility to treatment with leukotriene modifiers

RABINOVITCH NATHAN1 citations37